Spots Global Cancer Trial Database for Clinical Evaluation of Genetron IDH1 PCR Kit in Glioma Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Clinical Evaluation of Genetron IDH1 PCR Kit in Glioma Patients
Official Title: Clinical Evaluation of Genetron IDH1 PCR Kit in Glioma Patients
Study ID: NCT05100173
Interventions
Study Description
Brief Summary: The purpose of this trail is to evaluate the performance of Genetron IDH1 PCR Kit in Glioma patients using real-time PCR method.
Detailed Description: This trial follows the principle of synchronous blinding. The enrolled cases are coded, and the enrolled samples are detected with Genetron IDH1 PCR Kit and Sanger sequencing method. The results were determined independently according to the cutoff values or interpretation requirements provided by each method. Combined with the results of clinicopathological classification, the incidence of IDH1 gene R132H mutation in different subtypes was counted to evaluate the clinical performance of the Genetron IDH1 PCR Kit.
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
The First Hospital of Jilin University, Jilin, , China
Huashan Hospital of Fudan University, Shanghai, , China
West China Hospital of Sichuan University, Sichuan, , China
The Second Affiliated Hospital of Zhejiang University, Zhejiang, , China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
